National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 9/17/2021 release of VAERS data:

Found 2,302 cases where Vaccine is COVID19 and Manufacturer is JANSSEN and Symptom is Cerebral venous sinus thrombosis or Cerebral venous thrombosis or Coagulopathy or Deep vein thrombosis or Disseminated intravascular coagulation or Embolism or Idiopathic thrombocytopenic purpura or Immune thrombocytopenia or Immune thrombocytopenic purpura or Ischaemic stroke or Myocardial infarction or Petechiae or Pulmonary embolism or Purpura or Thrombocytopenia or Thrombosis or Vasculitis



Case Details

This is page 2 out of 231

Result pages: prev   1 2 3 4 5 6 7 8 9 10 11   next


VAERS ID: 1107565 (history)  
Form: Version 2.0  
Age: 18.0  
Sex: Female  
Location: New York  
Vaccinated:2021-03-08
Onset:2021-03-14
   Days after vaccination:6
Submitted: 0000-00-00
Entered: 2021-03-17
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN - / 1 - / IM

Administered by: Private       Purchased by: ?
Symptoms: Arthralgia, Computerised tomogram thorax abnormal, Fibrin D dimer increased, Flank pain, Laboratory test, Lung infiltration, Pain, Painful respiration, Pulmonary embolism, White blood cell count increased, X-ray
SMQs:, Haemorrhage laboratory terms (broad), Interstitial lung disease (narrow), Neuroleptic malignant syndrome (broad), Retroperitoneal fibrosis (broad), Embolic and thrombotic events, venous (narrow), Cardiomyopathy (broad), Eosinophilic pneumonia (broad), Arthritis (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Infective pneumonia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: cortef 5mg tid florinef 0.5mg bid birth control pill (name unknown)
Current Illness: none
Preexisting Conditions: congenital adrenal hyperplasia
Allergies: nka
Diagnostic Lab Data: 03/16/2021 ct pe study: bilateral lower lung pulmonary emboli and lower lung patchy infiltrates 03/16/2021: wbc 14.8 03/16/2021: d dimer 3970
CDC Split Type:

Write-up: On 3/14/21 patient started with left flank pain that radiated to left shoulder and increased pain while taking a deep breath. Mother called on 3/16/21 and patient was seen in primary clinic for issue. She had labs and xray done. Xray showed possible mild opacity in left lower lobe and to do ct scan. Ct pe study done same day showing bilateral lower lung pulmonary emboli and lower lung patchy infiltrates. Patients pain progressively got worsened and was seen in the er to be transferred to outgoing facility for care.


VAERS ID: 1108312 (history)  
Form: Version 2.0  
Age: 68.0  
Sex: Female  
Location: New Hampshire  
Vaccinated:2021-03-07
Onset:2021-03-09
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-03-17
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN - / UNK - / -

Administered by: Private       Purchased by: ?
Symptoms: Capillary leak syndrome, Condition aggravated, Death, Disseminated intravascular coagulation, Distributive shock, Renal failure
SMQs:, Rhabdomyolysis/myopathy (broad), Acute renal failure (narrow), Haemorrhage terms (excl laboratory terms) (narrow), Retroperitoneal fibrosis (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (broad), Torsade de pointes, shock-associated conditions (broad), Hypovolaemic shock conditions (broad), Toxic-septic shock conditions (narrow), Anaphylactic/anaphylactoid shock conditions (narrow), Hypoglycaemic and neurogenic shock conditions (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Haemodynamic oedema, effusions and fluid overload (narrow), Chronic kidney disease (narrow), Hypersensitivity (narrow), Tumour lysis syndrome (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-16
   Days after onset: 6
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 7 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: elavil, lisinopril, simvastatin, terbutaline, theophylline
Current Illness: none
Preexisting Conditions: Idiopathic Capillary Leak Syndrome
Allergies: None
Diagnostic Lab Data:
CDC Split Type:

Write-up: Severe exacerbation of idiopathic capillary leak syndrome 48 hours following administeration of Janssen vaccine leading to profound vasodilatory shock, renal failure and DIC and death


VAERS ID: 1108362 (history)  
Form: Version 2.0  
Age: 71.0  
Sex: Female  
Location: Missouri  
Vaccinated:2021-03-09
Onset:2021-03-10
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-03-17
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 1805029 / 1 LA / IM

Administered by: Pharmacy       Purchased by: ?
Symptoms: Bedridden, Dizziness, Fatigue, Injection site swelling, Lethargy, Peripheral swelling, Petechiae
SMQs:, Cardiac failure (broad), Angioedema (broad), Haemorrhage terms (excl laboratory terms) (narrow), Anticholinergic syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Extravasation events (injections, infusions and implants) (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Vestibular disorders (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: Ditropan
Current Illness: n/a
Preexisting Conditions: n/a
Allergies: Tetracycline
Diagnostic Lab Data:
CDC Split Type:

Write-up: Day 1: no sx, Day 2: extreme fatigue . Dizzy lightheaded Day 3: profound lethargy + dizzy & lightheaded . bedridden Day 4: profound lethargy dizzy + lightheaded bedridden Day 5: visit to urgent care. rx for keflex for injection site sub cutaeneous lump. c/o right arm swollen, petechia, right torso petechia. dizzy lightheaded. Patient reports she is blood type AB negative Day 6: visit to PCP


VAERS ID: 1108465 (history)  
Form: Version 2.0  
Age: 50.0  
Sex: Female  
Location: Utah  
Vaccinated:2021-03-11
Onset:2021-03-12
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-03-17
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN - / UNK - / -

Administered by: Pharmacy       Purchased by: ?
Symptoms: Atrial fibrillation, Blood test, Cerebrovascular accident, Computerised tomogram, Magnetic resonance imaging, Thrombosis
SMQs:, Supraventricular tachyarrhythmias (narrow), Ischaemic central nervous system vascular conditions (narrow), Haemorrhagic central nervous system vascular conditions (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 2 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: NA
Current Illness: NA
Preexisting Conditions: NA
Allergies: NA
Diagnostic Lab Data: MRI, Cat Scan and blood tests
CDC Split Type:

Write-up: Heart was in A-fib, blood clot formed and had a Left Posterior Parietal Stroke


VAERS ID: 1110436 (history)  
Form: Version 2.0  
Age: 62.0  
Sex: Female  
Location: Texas  
Vaccinated:2021-03-06
Onset:2021-03-06
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-03-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 1805018 / 1 LA / IM

Administered by: Other       Purchased by: ?
Symptoms: Chills, Flushing, Heart rate increased, Hyperhidrosis, Myocardial infarction, Palpitations, Pyrexia, Thyroid function test abnormal
SMQs:, Anaphylactic reaction (broad), Neuroleptic malignant syndrome (broad), Myocardial infarction (narrow), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Embolic and thrombotic events, arterial (narrow), Cardiomyopathy (broad), Hypothyroidism (broad), Hyperthyroidism (broad), Hypersensitivity (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad), Dehydration (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Synthroid 88mg, Olnesartan, Pantroprozol, Caltrate 600, fish oil, b12 sublingual, Multivitamin, Bare Aspirin 81mg, Colace, Probiotic, cranberry, Sublingual allergy drops
Current Illness: no
Preexisting Conditions: Hypothroidism, Hypertension
Allergies: Sudafed, morphine
Diagnostic Lab Data: CBC-tyroid levels elevated
CDC Split Type: vsafe

Write-up: A few minutes after the vaccine my heart began palpatating and I began sweating profusely. My vitals were checked, I was given water and moved to a cooler area of the facility. HR was still elevated but I wasnt feeling as flushed. By 4pm that evening I began having having chills and a fever of 100-100.4 which lasted about 4hrs. Later that evening my HR elevated to 125 with the feeling of feeling I was having a heart attack. By that Wed. my HR was still at 125 in motion and about 75 still so I went to visit my PCP on Thurs and when I arrived the HR was 77 but during the visit it elevated to 125 and blood work was done resulting in my tyroid level elevated and since getting the vaccine my HR had been up and down. When in motion its elevated and when sitting its around 75.


VAERS ID: 1112120 (history)  
Form: Version 2.0  
Age: 76.0  
Sex: Male  
Location: Illinois  
Vaccinated:2021-03-09
Onset:2021-03-11
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-03-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 1805025 / 1 - / IM

Administered by: Other       Purchased by: ?
Symptoms: Alanine aminotransferase increased, Albumin globulin ratio, Aspartate aminotransferase increased, Asthenia, Blood albumin decreased, Blood alkaline phosphatase, Blood bilirubin increased, Blood calcium decreased, Blood chloride decreased, Blood creatine phosphokinase increased, Blood creatinine increased, Blood lactic acid, Blood potassium decreased, Blood sodium, Blood urea increased, COVID-19, COVID-19 pneumonia, Carbon dioxide normal, Cardiomegaly, Cholelithiasis, Computerised tomogram thorax abnormal, Cough, Dizziness, Electrocardiogram normal, Fibrin D dimer increased, Glomerular filtration rate decreased, Glucose urine absent, Haematocrit decreased, Haemoglobin decreased, Influenza A virus test negative, Influenza virus test negative, Lung opacity, Lymphocyte count increased, Lymphocyte percentage decreased, Mean cell haemoglobin concentration normal, Mean cell haemoglobin decreased, Mean cell volume decreased, Mean platelet volume normal, Monocyte count normal, Monocyte percentage, Neutrophil count normal, Oropharyngeal pain, Pain, Platelet count normal, Pleural effusion, Pneumonia, Protein total normal, Protein urine absent, Pulmonary embolism, Pyrexia, Red blood cell count normal, Red blood cell nucleated morphology, Red blood cell sedimentation rate increased, Red cell distribution width, Red cell distribution width increased, Renal cyst, Respiratory tract congestion, SARS-CoV-2 test positive, Scan with contrast, Troponin I increased, Urine analysis normal, White blood cell count normal, pH urine normal
SMQs:, Rhabdomyolysis/myopathy (broad), Acute renal failure (broad), Cardiac failure (broad), Liver related investigations, signs and symptoms (narrow), Anaphylactic reaction (broad), Acute pancreatitis (broad), Haematopoietic erythropenia (broad), Haematopoietic leukopenia (broad), Haemorrhage laboratory terms (broad), Interstitial lung disease (narrow), Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (broad), Myocardial infarction (narrow), Anticholinergic syndrome (broad), Retroperitoneal fibrosis (broad), Embolic and thrombotic events, venous (narrow), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Biliary system related investigations, signs and symptoms (narrow), Gallbladder related disorders (narrow), Gallstone related disorders (narrow), Guillain-Barre syndrome (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Cardiomyopathy (broad), Eosinophilic pneumonia (broad), Vestibular disorders (broad), Chronic kidney disease (broad), Tumour lysis syndrome (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (narrow), Infective pneumonia (narrow), Hypokalaemia (narrow), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 2 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Current Outpatient Medications: ? amoxicillin (AMOXIL) 875 MG tablet, Take 1 tablet (875 mg) by mouth 2 times daily for 7 days, Disp: 14 tablet, Rfl: 0 ? atenolol (TENORMIN) 25 MG tablet, Take 1 tablet (25 mg) by mouth daily, Disp: 30 ta
Current Illness:
Preexisting Conditions:
Allergies: Allergen Reactions ? Darvocet-N 100 [Kdc:Acetaminophen+Sorbitan+Propoxyphene
Diagnostic Lab Data: Final Result EXAMINATION: CTA of the chest CLINICAL HISTORY: 76 years Male,elevated ddimer COMPARISON: There is no prior similar study available for correlation. TECHNIQUE: Axial imaging along with 2-D and 3-D postprocessing performed from the level of the thoracic inlet to the kidneys following the administration of IV contrast and utilizing CTA protocol. This exam was performed according to our departmental dose-optimization program, which includes automated exposure control, adjustment of the mA and/or kV according to patient size and/or use of iterative reconstruction technique. IV CONTRAST: 100 mL TOTAL DLP: 953 mGy-cm FINDINGS: There are filling defects in the bilateral segmental and subsegmental pulmonary arteries. There is a small right pleural effusion. The heart is enlarged. There is no pericardial effusion. The thoracic aorta is within normal limits. Severe peripheral groundglass opacities identified predominantly in the lower lungs. There are several small stones in the gallbladder. Multiple cysts identified in the visualized right kidney. IMPRESSION: Multiple bilateral segmental and subsegmental PE Large bilateral groundglass opacities worrisome for severe Covid pneumonia. Correlate with clinical findings. Multiple small gallstones. Multiple right renal cysts EKG nsr no acute changes no st changes normal axis CBC W AUTO DIFF Collection Time: 03/18/21 9:57 AM Result Value Ref Range White Blood Cell Count 5.4 4.8 - 9.6 THOUS/uL Red Blood Cell Count 4.86 4.33 - 5.59 MIL/uL Hemoglobin 12.6 (L) 13.1 - 16.8 GM/DL Hematocrit 36.9 (L) 38.8 - 49.0 % Mean Corpuscular Volume 75.9 (L) 82.7 - 94.4 FL Mean Corpuscular Hemoglobin 25.9 (L) 27.7 - 32.6 PG Mean Corpuscular Hemoglobin Conc 34.1 32.4 - 35.7 G/DL Rdwcv 15.9 (H) 11.6 - 13.9 % Rdwsd 43.6 36.0 - 46.1 FL Platelet Count 157 154 - 364 THOUS/uL Mean Platelet Volume 9.8 8.7 - 11.7 FL Nucleated Red Blood Cells 0.0 0.0 /100 WBC''S Abs NRBC 0.0 0.0 THOUS/uL Seg 86.0 (H) 46.9 - 70.0 % Lymphs 9.0 (L) 19.1 - 41.2 % Monocytes 5.0 (L) 6.1 - 12.3 % Neutrophils Absolute Count 4.6 1.7 - 8.7 THOUS/uL Lymphocytes Absolute Count 0.5 (L) 0.8 - 5.6 THOUS/uL Monocytes Absolute Count 0.3 0.1 - 1.0 THOUS/uL RBC Morphology NORMAL NORMAL Differential Type AUTO Platelet Estimate ADEQUATE ADEQUATE COMPREHENSIVE METABOLIC PANEL Collection Time: 03/18/21 9:57 AM Result Value Ref Range Glucose 102 (H) 65 - 100 MG/DL Blood Urea Nitrogen 27 (H) 7 - 18 MG/DL Creatinine 1.4 (H) 0.7 - 1.3 MG/DL Sodium 128 (L) 136 - 145 MMOL/L Potassium 3.0 (L) 3.5 - 5.1 MMOL/L Chloride 90 (L) 98 - 107 MMOL/L Co2 25 21 - 32 MMOL/L Calcium 8.6 8.5 - 10.1 MG/DL Protein Total 7.2 6.4 - 8.2 G/DL Albumin 3.2 (L) 3.4 - 5.0 G/DL A/G Ratio 0.8 0.8 - 2.0 Alkaline Phosphatase 86 46 - 116 U/L Alt (SGPT) 50 16 - 63 U/L AST(SGOT) 79 (H) 15 - 37 U/L Bilirubin, Total 1.1 (H) 0.2 - 1.0 MG/DL GFR Comment IF PATIENT IS AFRICAN AMERICAN, MULTIPLY RESULT BY 1.16 Est GFR 48 (L) $g90 ML/MIN/1.73sq.m LACTIC ACID, SERUM Collection Time: 03/18/21 9:57 AM Result Value Ref Range Lactate 1.5 0.4 - 2.0 MMOL/L TROPONIN Collection Time: 03/18/21 9:57 AM Result Value Ref Range Troponin I 0.11 (H) 0.00 - 0.06 ng/mL D-DIMER,QUANTITATIVE Collection Time: 03/18/21 9:57 AM Result Value Ref Range D-Dimer 1,550 (HH) 0 - 400 NG/ML FEU CK (CPK) CREATINE PHOSPHOKINASE Collection Time: 03/18/21 9:57 AM Result Value Ref Range Creatine Kinase Total 694 (HH) 39 - 308 U/L SEDIMENTATION RATE (SED RATE) Collection Time: 03/18/21 9:57 AM Result Value Ref Range Sedimentation Rate, Erythrocyte 31 (H) 0 - 15 MM/HR INFLUENZA A AND B ANTIGEN Collection Time: 03/18/21 9:58 AM Specimen: NARES Result Value Ref Range Influenza A NEGATIVE NEGATIVE Influenza B NEGATIVE NEGATIVE FHC COVID ANTIGEN Collection Time: 03/18/21 9:59 AM Result Value Ref Range FHC COV AG PRESUMPTIVE POSITIVE REPORTED TO URINALYSIS WITH REFLEX TO CULTURE, IF INDICATED Collection Time: 03/18/21 11:08 AM Specimen: URINE,CLEAN CATCH (CCMS) Result Value Ref Range Glucose UA NEGATIVE NEGATIVE MG/DL Protein UA 2+ (A) NEGATIVE MG/DL Bilirubin UA NEGATIVE NEGATIVE Urobilinogen UA 0.2 0.2 - 1.0 MG/DL pH UA 5.5 5.0 - 8.0 Blood UA 2+ (A) NEGATIVE Ketones UA 2+ (A) NEGATIVE MG/DL Nitrite UA NEGATIVE NEGATIVE Leukocyte Esterase UA NEGATIVE NEGATIVE UR Appearance CLEAR CLEAR Specific Gravity UA 1.025 1.000 - 1.030 Color YELLOW YELLOW Site CCMS Comment, Urine Culture NOT INDICATED RBC Urine 0 to 5 <3 /HPF WBC Urine 0 to 5 <5 /HPF Bacteria RARE (A) NONE /HPF Mucus RARE /LPF
CDC Split Type:

Write-up: 3/18/21 ER Triage Nurse Note: "To er via EMS for eval of weakness and dizziness. States he started with sore throat and head congestion last week. Seen PCP Monday 03-15-21. Started amoxil. Took it for 2 days and became dizzy so he quit taking it. Dizziness got worse and came to ER." 3/18/21 ER HPI: 76 y.o. male who presents with c/o weakness cough and fever for the past seven days. Pt report sx are mod better with rest and worse with movement. Transferred to Hospital, dx: pneumonia dt covid-19 virus


VAERS ID: 1112122 (history)  
Form: Version 2.0  
Age: 43.0  
Sex: Male  
Location: California  
Vaccinated:2021-03-13
Onset:2021-03-15
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2021-03-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 1805029 / 1 LA / IM

Administered by: Private       Purchased by: ?
Symptoms: Aggression, Mood altered, Pulmonary embolism, Pulseless electrical activity, Respiratory arrest, Sudden death
SMQs:, Torsade de pointes/QT prolongation (broad), Anaphylactic reaction (broad), Arrhythmia related investigations, signs and symptoms (broad), Shock-associated circulatory or cardiac conditions (excl torsade de pointes) (narrow), Dementia (broad), Embolic and thrombotic events, venous (narrow), Acute central respiratory depression (narrow), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Hostility/aggression (narrow), Cardiomyopathy (broad), Cardiac arrhythmia terms, nonspecific (narrow), Depression (excl suicide and self injury) (broad), Hypersensitivity (broad), Respiratory failure (narrow)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-03-15
   Days after onset: 0
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Macrobid 100 mg po BID Cefepime 2g daily (3/12-3/19) Dilaudid 2 mg po PRN pain gabapentin 600 mg BID Methotrexate qFriday Metoprolol 25 mg BID Odefsey (HAART) Mirtazipine daily Glipizide, insulin for DM2
Current Illness: Complicated lower UTI (hospitalized for this- received vaccine in house) - MDR bacteria
Preexisting Conditions: Neurosarcoidosis Transverse myelitis with lower paraplegia HIV positive (on HAART) DM2 MDD
Allergies: PCN Cipro Ertapenem Fosfomycin
Diagnostic Lab Data: None. Patient was being discharged. I suspected a massive PE however pt was on DVT prophylaxis. The coroner refused to do an autopsy so cause of death was not known but it was a highly unusual and unexpected outcome.
CDC Split Type:

Write-up: Patient was admitted for Multi drug resistant UTI (for which he has been admitted many times before). Was hospitalized for 3 days while awaiting cultures, hemodynamically stable, with no lab abnormalities. On the day of discharge (sensitivities to UTI came back, pt to be discharged on cefepime, had PICC line) pt got up from bed, sat on the edge of the bed and was being given belongings by the nurse, alert and oriented and in a pleasant mood, when suddenly pt grabbed at his chest and stated "I can''t breathe" and became combative and altered when O2 was attempted to be placed on pt''s face; then pt had PEA arrest x3 and unable to achieve ROSC.


VAERS ID: 1112768 (history)  
Form: Version 2.0  
Age: 55.0  
Sex: Male  
Location: New York  
Vaccinated:2021-03-06
Onset:2021-03-15
   Days after vaccination:9
Submitted: 0000-00-00
Entered: 2021-03-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 1805022 / 1 LA / IM

Administered by: Other       Purchased by: ?
Symptoms: Deep vein thrombosis, Pelvic venous thrombosis, Ultrasound scan abnormal
SMQs:, Embolic and thrombotic events, venous (narrow), Malignancy related therapeutic and diagnostic procedures (narrow), Thrombophlebitis (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Tacrolimus, Aspirin, Everolimus, Famotidine, Pravastatin, Vascepa, multivitamin, Iron supplements, Magnesium, Prednisone
Current Illness: status post heart transplant
Preexisting Conditions: status post heart transplant with cardiac allograft vasculopathy
Allergies: None
Diagnostic Lab Data: 3/16/2021 Ultrasound of the Lower Extremities 3/16/2021 hospitalization at Medical Center for management of acute DVT 3/19/2021 Interventional Cardiology for endovascular management of acute vascular thrombosis
CDC Split Type:

Write-up: Patient developed an extensive acute, occlusive thrombus in the external iliac, common femoral, popliteal, and gastrocnemius veins


VAERS ID: 1112822 (history)  
Form: Version 2.0  
Age: 65.0  
Sex: Female  
Location: Illinois  
Vaccinated:2021-03-10
Onset:2021-03-17
   Days after vaccination:7
Submitted: 0000-00-00
Entered: 2021-03-18
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 1805031 / UNK LA / IM

Administered by: Unknown       Purchased by: ?
Symptoms: Computerised tomogram thorax, Condition aggravated, Pulmonary embolism
SMQs:, Embolic and thrombotic events, venous (narrow)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 1 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Calcium. Vit d. Metamucil. Eye vitamins.
Current Illness: Pulmonary embolism
Preexisting Conditions: None
Allergies: Penicillin
Diagnostic Lab Data: Ct of chest
CDC Split Type:

Write-up: Pulmonary embolism one week after injection


VAERS ID: 1114806 (history)  
Form: Version 2.0  
Age: 45.0  
Sex: Female  
Location: Virginia  
Vaccinated:2021-03-06
Onset:2021-03-12
   Days after vaccination:6
Submitted: 0000-00-00
Entered: 2021-03-19
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN - / 1 - / IM

Administered by: School       Purchased by: ?
Symptoms: Angiogram cerebral abnormal, Brain death, Brain herniation, Cerebral haematoma, Cerebral haemorrhage, Cerebral mass effect, Cerebral venous thrombosis, Cerebral ventricle dilatation, Computerised tomogram head abnormal, Endotracheal intubation, Headache, Hemiparesis, Mental status changes, Posturing, Retching, Thrombocytopenia
SMQs:, Angioedema (broad), Haematopoietic thrombocytopenia (narrow), Haemorrhage terms (excl laboratory terms) (narrow), Systemic lupus erythematosus (broad), Ischaemic central nervous system vascular conditions (narrow), Haemorrhagic central nervous system vascular conditions (narrow), Dementia (broad), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Embolic and thrombotic events, venous (narrow), Dystonia (broad), Thrombophlebitis (broad), Psychosis and psychotic disorders (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Cardiomyopathy (broad), Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (narrow), Respiratory failure (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? Yes
Birth Defect? No
Died? Yes
   Date died: 2021-03-18
   Days after onset: 5
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 2 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Fluoxetine
Current Illness: Depression
Preexisting Conditions:
Allergies: NKMA, No allergies
Diagnostic Lab Data: CT Angiogram of the head 3/17/21: "The supraclinoid ICAs are patent bilaterally. The right MCA is elevated by the large right hemispheric hematoma. There is no occlusion or significant stenosis involving the right MCA. The left MCA and bilateral ACAs are within normal limits. The intracranial vertebral arteries, left PICA, basilar artery and both PCAs are patent. There is no aneurysm or AVM. The evaluation of the venous structures is limited on this CTA but there is no opacification of the right transverse and sigmoid sinuses, suggestive of dural sinus thrombosis. Large right hemispheric hematoma is demonstrated with significant right-to-left midline shift measuring approximately 16 mm. Effacement of the right lateral ventricle and dilation of the left lateral ventricle. Right-sided transtentorial herniation is noted. IMPRESSION: 1. Suspect right transverse and sigmoid sinus dural sinus thrombosis. This can be confirmed with CTV if clinically necessary 2. No evidence of aneurysm or AVM to account for the right hemispheric intraparenchymal hematoma. Significant right-to-left midline shift and downward transtentorial herniation is noted."
CDC Split Type:

Write-up: Diagnosis: Cortical vein thrombosis, massive intracerebral hemorrhage with tentorial herniation, thrombocytopenia. Clinical Presentation and Course: 1 week after receiving Janssen COVID19 vaccination, patient developed gradually worsening headache. On March 17th, patient presented to Hospital with dry heaving, sudden worsening of headache and L sided weakness. Evaluation with head CT revealed a large R temporoparietal intraparenchymal hemorrhage with 1.3cm midline shift. She ended up getting intubated for worsening mental status. On evaluation at arrival in Medical Center, she was noted to have extensor posturing. Repeat imaging revealed worsening midline shift to 1.6cm. CTA showed cortical vein thrombosis involving the right transverse and sigmoid sigmoid sinus with tentorial herniation. Patient developed brain herniation and brain death was pronounced on March 18th, 2021.


Result pages: prev   1 2 3 4 5 6 7 8 9 10 11   next

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=2&SYMPTOMS[]=Cerebral_venous_sinus_thrombosis_%2810083037%29&SYMPTOMS[]=Cerebral_venous_thrombosis_%2810008138%29&SYMPTOMS[]=Coagulopathy_%2810009802%29&SYMPTOMS[]=Deep_vein_thrombosis_%2810051055%29&SYMPTOMS[]=Disseminated_intravascular_coagulation_%2810013442%29&SYMPTOMS[]=Embolism_%2810061169%29&SYMPTOMS[]=Idiopathic_thrombocytopenic_purpura_%2810021245%29&SYMPTOMS[]=Immune_thrombocytopenia_%2810083842%29&SYMPTOMS[]=Immune_thrombocytopenic_purpura_%2810074667%29&SYMPTOMS[]=Ischaemic_stroke_%2810061256%29&SYMPTOMS[]=Myocardial_infarction_%2810028596%29&SYMPTOMS[]=Petechiae_%2810034754%29&SYMPTOMS[]=Pulmonary_embolism_%2810037377%29&SYMPTOMS[]=Purpura_%2810037549%29&SYMPTOMS[]=Thrombocytopenia_%2810043554%29&SYMPTOMS[]=Thrombosis_%2810043607%29&SYMPTOMS[]=Vasculitis_%2810047115%29&VAX=COVID19&VAXMAN=JANSSEN


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166